Skip to main content
SpringerLink
Log in

Incretin-based drugs: risk of pancreatitis assessed

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. See also Reactions 1492 p1; 803100280

Reference

  • Li L, et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. BMJ 348: g2366 [19 pages], 15 Apr 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g2366

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Incretin-based drugs: risk of pancreatitis assessed. Reactions Weekly 1499, 3 (2014). https://doi.org/10.1007/s40278-014-0459-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-0459-8

Search

Navigation